drugset / Trial / NCT05023343
Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to examine whether the administration of the TQL block cause motor block of the lumbar plexus and thereby quadriceps muscle weakness. The investigators hypothesise that the administration of a unilateral TQL block does not cause quadriceps muscle weakness compared to a placebo block.
Timeline
- Start
- 2021-10-02
- Primary completion
- 2021-11-28
- Completion
- 2021-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ropivacaine | Other / unclassified | 0.75 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 30 ml | Other |
Indications
No indication recorded.